Harnessing the Power of mRNA
Our mRNA platform bridges validated biology and clinical application by engineering therapeutic mRNA constructs in concert with advanced lipid nanoparticle delivery systems. This integrated approach safeguards the therapeutic payload, facilitates targeted cellular uptake, and enables reproducible protein expression at scale. Spanning cancers and cardiovascular diseases, the platform's modular architecture accommodates diverse drug modalities to accelerate development without compromising precision or scalability.
Our candidate discovery is guided by a rigorous process spanning target selection through development-ready nomination. Each program is grounded in a well-characterized therapeutic rationale, with construct design systematically refined to achieve optimal potency, duration, and tissue localization. Candidates undergo parallel evaluation across clinically relevant biological models and formulation conditions, enabling disciplined prioritization of programs that demonstrate the efficacy, tolerability, and developability characteristics essential for successful clinical advancement.
Candidate Discovery
Design and Synthesis Platform
Our Multi-Dimensional Optimization Platform unifies rapid construct generation with sequence and formulation design into a single, integrated system. By generating diverse mRNA architectures in parallel to precisely tune translation efficiency, stability, and expression kinetics, we accelerate the path from target identification to high-confidence leads. Each candidate is rigorously evaluated to rapidly identify candidates that strike the critical balance between efficacy and safety, positioned for scalable clinical development.